Collects extensive phenotypic and genotypic detail about a very large, population-based prospective study. UK Biobank aims to encourage and provide access to data and samples for health-related research in the public interest by all bona fide researchers from the academic, charity, public, and commercial sectors. The database enables the prevention, diagnosis and treatment of a wide range of serious and life-threatening illnesses – including cancer, heart diseases, stroke, diabetes, arthritis, osteoporosis, eye disorders, depression and forms of dementia.
Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK; Department of Statistics, University of Oxford, Oxford, UK; Melbourne Integrative Genomics and the Schools of Mathematics and Statistics, and BioSciences, The University of Melbourne, Parkville, VIC, Australia; Murdoch Children’s Research Institute, Parkville, VIC, Australia; Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland; Swiss Institute of Bioinformatics, University of Geneva, Geneva, Switzerland; Institute of Genetics and Genomics in Geneva, University of Geneva, Geneva, Switzerland; Illumina Ltd, Chesterford Research Park, Little Chesterford, Essex, UK; Nuffield Department of Clinical Neurosciences, Division of Clinical Neurology, John Radcliffe Hospital, University of Oxford, Oxford, UK; UK Biobank, Adswood, Stockport, Cheshire, UK; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK
UK Biobank funding source(s)
Supported by Wellcome Trust Core Awards 090532/Z/09/Z and 203141/Z/16/Z and grants 095552/Z/11/Z, 100956/Z/13/Z and 100308/Z/12/Z, by European Research Council grant 617306 and by Australian NHMRC Career Development Fellowship 1053756.